Bayesian Capital Management LP Makes New Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Bayesian Capital Management LP acquired a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 6,160 shares of the medical equipment provider's stock, valued at approximately $3,215,000.

Several other hedge funds have also recently bought and sold shares of ISRG. M.E. Allison & CO. Inc. bought a new stake in Intuitive Surgical during the fourth quarter valued at about $449,000. Seilern Investment Management Ltd bought a new stake in Intuitive Surgical during the 4th quarter valued at approximately $82,517,000. Sycomore Asset Management grew its holdings in Intuitive Surgical by 27.4% in the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider's stock valued at $9,214,000 after buying an additional 4,079 shares during the last quarter. China Universal Asset Management Co. Ltd. increased its position in Intuitive Surgical by 5.6% in the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider's stock worth $5,138,000 after buying an additional 525 shares during the period. Finally, Wealth Enhancement Advisory Services LLC lifted its holdings in shares of Intuitive Surgical by 73.2% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 270,029 shares of the medical equipment provider's stock worth $132,657,000 after buying an additional 114,149 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock traded up $5.69 during trading on Wednesday, reaching $536.15. 1,311,349 shares of the company traded hands, compared to its average volume of 1,626,933. The firm has a market capitalization of $192.17 billion, a PE ratio of 83.64, a P/E/G ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a 1-year low of $379.67 and a 1-year high of $616.00. The company has a 50 day moving average price of $502.67 and a 200-day moving average price of $534.43.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The firm had revenue of $2.25 billion during the quarter, compared to analysts' expectations of $2.19 billion. During the same quarter last year, the firm posted $1.50 earnings per share. Equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analyst Ratings Changes

A number of research firms recently weighed in on ISRG. Raymond James lifted their target price on Intuitive Surgical from $560.00 to $688.00 and gave the stock an "outperform" rating in a research report on Friday, January 24th. Barclays decreased their price objective on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a report on Thursday, April 24th. Piper Sandler reduced their target price on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 23rd. BTIG Research set a $560.00 target price on shares of Intuitive Surgical and gave the stock a "buy" rating in a research note on Monday, April 14th. Finally, UBS Group raised their target price on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a "neutral" rating in a research note on Monday, January 27th. Five investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $598.95.

Insiders Place Their Bets

In related news, VP Fredrik Widman sold 810 shares of the firm's stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $573.78, for a total value of $464,761.80. Following the transaction, the vice president now owns 473 shares of the company's stock, valued at approximately $271,397.94. This trade represents a 63.13 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Jamie Samath sold 269 shares of Intuitive Surgical stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $590.00, for a total value of $158,710.00. Following the transaction, the chief financial officer now directly owns 3,282 shares in the company, valued at approximately $1,936,380. The trade was a 7.58 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 33,313 shares of company stock worth $17,229,143. Insiders own 0.70% of the company's stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.